Hologic (HOLX) Reports In-Line Q2 EPS; Lowers Rev Guidance, Maintains EPS

Hologic (NASDAQ: HOLX) reported Q2 EPS of $0.53, in-line with the analyst estimate of $0.53. Revenue for the quarter came in at $789.3 million versus the consensus estimate of $781.84 million.

GUIDANCE:

Hologic sees FY2018 revenue of $3.18-3.21 million, versus the consensus of $3.25 million. Reiterating non-GAAP EPS guidance for the year.

For earnings history and earnings-related data on Hologic (HOLX) click here.

You May Also Be Interested In

• SanDisk stock target lifted at Bernstein to $3000 on new memory LTAs
• Where are we in this AI infrastructure investment cycle?
• AeroVironment (AVAV) Tops Q4 EPS by 36c